CL
RMTI icon

Croft-Leominster’s Rockwell Medical RMTI Stock Holding History

Croft-Leominster’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-100
Closed -$125K – 206
2013
Q3 		$125K Buy
+100
New +$67.9K 0.02% 175

Other funds holding RMTI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Croft-Leominster's RMTI Position: Q4 2013 in Review

Croft-Leominster sold out of Rockwell Medical (RMTI) in Q4 2013, closing a stake of 100 shares — an estimated $125K sold.

Croft-Leominster first reported a position in RMTI in Q3 2013 and held it in 1 quarter. The position peaked at $125K in Q3 2013. 92 funds tracked by Wall St. Rank hold RMTI as of Q4 2013.

  • Croft-Leominster reported no remaining Rockwell Medical position as of Q4 2013 after selling out during the quarter.
  • Croft-Leominster sold 100 Rockwell Medical shares in Q4 2013, an estimated $125K.
  • Croft-Leominster first reported a position in Rockwell Medical in Q3 2013 and held it in 1 quarter.
  • Croft-Leominster's Rockwell Medical position peaked at $125K in Q3 2013.
  • 92 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2013.

Based on Croft-Leominster's 13F filing for Q4 2013, filed 12 Feb 2014.